Cyclosporine in chronic idiopathic urticaria: A double-blind, randomized, placebo-controlled trial

Journal of the American Academy of Dermatology

Volumn 55, Issue 4, 2006, Pages 705-709

  Vena, Gino A ^a   Cassano, Nicoletta ^a   Colombo, Delia ^b   Peruzzi, Elena ^b   Pigatto, Paolo ^c  

^a UNIVERSITY OF BARI   (Italy)

^b Medical Department   (Italy)

^c UNIVERSITY OF MILAN   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CETIRIZINE; CYCLOSPORIN A; PLACEBO;

ACUTE GASTROENTERITIS; ADULT; ARTHRALGIA; ARTICLE; BACKACHE; CLINICAL TRIAL; CONJUNCTIVITIS; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE EXACERBATION; DIZZINESS; DOUBLE BLIND PROCEDURE; DRUG EFFECT; DRUG FEVER; DRUG INDUCED HEADACHE; DRUG SAFETY; FEMALE; FLU LIKE SYNDROME; FLUSHING; FOLLOW UP; GASTRITIS; GASTROENTERITIS; HUMAN; HYPERTENSION; HYPERTRICHOSIS; MAJOR CLINICAL STUDY; MALE; MIGRAINE; PARESTHESIA; PRECORDIAL PAIN; PRIORITY JOURNAL; PRURITUS; RANDOMIZED CONTROLLED TRIAL; SIDE EFFECT; TIME SERIES ANALYSIS; TREATMENT DURATION; TREATMENT FAILURE; TREMOR; UPPER ABDOMINAL PAIN; URTICARIA;

ADULT; CHRONIC DISEASE; CYCLOSPORINE; DERMATOLOGIC AGENTS; DOUBLE-BLIND METHOD; FEMALE; HUMANS; MALE; URTICARIA;

EID: 33749021931     PISSN: 01909622     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jaad.2006.04.078     Document Type: Article

References (17)

1. Fradin M.S., Ellis C.N., Goldfarb M.T., and Voorhees J.J. Oral cyclosporine for severe chronic idiopathic urticaria and angioedema. J Am Acad Dermatol 25 (1991) 1065-1067
2. Barlow R.J., Kobza Black A., and Greaves M.W. Treatment of severe, chronic urticaria with cyclosporin A. Eur J Dermatol 3 (1993) 273-275
3. Vena G.A., Curatoli G., Fiordalisi F., Foti C., and D'Argento V. La ciclosporina A nel trattamento dell'orticaria cronica idiopatica severa. Studio clinico su otto casi. Boll Dermatol Allergol Profess 8 (1993) 309-318
4. Curatoli G., D'Argento V., Fiordalisi F., and Vena G.A. Trattamento dell'orticaria cronica: chetotifene versus cetirizina in schema sequenziale con ciclosporina A. Boll Dermatol Allergol Profess 11 (1996) 113-118
5. Toubi E., Blant A., Kessel A., and Golan T.D. Low-dose cyclosporin A in the treatment of severe chronic idiopathic urticaria. Allergy 52 (1997) 312-316
6. Ilter N., Gürer M.A., and Akkoca M.A. Short-term oral cyclosporine for chronic idiopathic urticaria. J Eur Acad Dermatol Venereol 12 (1999) 67-69
7. Loria M.P., Dambra P.P., D'Oronzio L., Nettis E., Pannofino A., Cavallo E., et al. Cyclosporin A in patients affected by chronic idiopathic urticaria: a therapeutic alternative. Immunopharmacol Immunotoxicol 23 (2001) 205-213
8. Di Gioacchino M., Di Stefano F., Cavallucci E., Verna N., Ramondo S., Paolini F., et al. Treatment of chronic idiopathic urticaria and positive autologous serum skin test with cyclosporine: clinical and immunological evaluation. Allergy Asthma Proc 24 (2003) 285-290
9. Bulbul Baskan E., Tunali S., Turker T., and Saricaoglu H. Comparison of short-and long-term cyclosporine A therapy in chronic idiopathic urticaria. J Dermatol Treat 15 (2004) 164-168
10. Breneman D., Bronsky E.A., Bruce S., Kalivas J.T., Klein G.L., Roth H.L., et al. Cetirizine and astemizole therapy for chronic idiopathic urticaria: a double-blind, placebo-controlled, comparative trial. J Am Acad Dermatol 33 (1995) 192-198
11. Finlay A.Y., and Khan G.K. Dermatology Life Quality Index (DLQI)-a simple practical measure for routine clinical use. Clin Exp Dermatol 19 (1994) 210-216
12. Grattan C.E., O'Donnell B.F., Francis D.M., Niimi N., Bralow R.J., Seed P.T., et al. Randomized double-blind study of cyclosporin in chronic 'idiopathic' urticaria. Br J Dermatol 143 (2000) 365-372
13. Cassano N., D'Argento V., and Vena G.A. Cyclosporin A in chronic idiopathic urticaria: An update. Int J Immunopathol Pharmacol 15 Suppl. Jan-Apr (2002) 13-18
14. Poon E., Seed P.T., Greaves M.W., and Kobza-Black A. The extent and nature of disability in different urticarial conditions. Br J Dermatol 140 (1999) 667-671
15. Thompson A.K., Finn A.F., and Schoenwetter W.F. Effect of 60 mg twice-daily fexofenadine HCl on quality of life, work and classroom productivity, and regular activity in patients with chronic idiopathic urticaria. J Am Acad Dermatol 43 (2000) 24-30
16. Lennox R.D., and Leahy M.J. Validation of the Dermatology Life Quality Index as an outcome measure for urticaria-related quality of life. Ann Allergy Asthma Immunol 93 (2004) 142-146
17. Toubi E., Bamberger E., and Kessel A. Prolonged cyclosporin-A treatment for severe chronic urticaria. Allergy 58 (2003) 535-536